Medicare Enrolled

Dr. Hagop Kantarjian, MD

Medical Oncology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
Registered in NPPES since 2006
NPI: 1316020290 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kantarjian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kantarjian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kantarjian

Dr. Hagop Kantarjian is a medical oncology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kantarjian performed 706 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kantarjian received a total of $564,542 from 29 pharmaceutical and/or device companies across 249 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kantarjian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 706 Medicare services $564,542 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
706
Medicare services
Bottom 42% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
405 $96 $283
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
257 $50 $171
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $26 $122
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
13 $93 $324
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$564,542
Total received (2018-2024)
Avg $80,649/year across 7 years
Top 3% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
249
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$84,164
2023
$102,307
2022
$64,188
2021
$77,103
2020
$47,279
2019
$98,239
2018
$91,262

Payments by company (2024)

Stemline Therapeutics Inc.
$24,000
Hikma Pharmaceuticals USA
$21,326
Sumitomo Pharma America, Inc.
$11,192
PFIZER INC.
$9,625
Amgen Inc.
$4,248
Ipsen Biopharmaceuticals, Inc
$3,045
Novartis Pharmaceuticals Corporation
$2,951
AstraZeneca Pharmaceuticals LP
$2,850
Takeda Pharmaceuticals U.S.A., Inc.
$2,790
Janssen Global Services, LLC
$1,012
ABBVIE INC.
$976
JAZZ PHARMACEUTICALS INC.
$149
Top 3 companies account for 67.2% of 2024 payments
All-time payments by company (2018-2024) ›
Hikma Pharmaceuticals USA
$98,428
PFIZER INC.
$75,325
Stemline Therapeutics Inc.
$54,000
Amgen Inc.
$52,237
ABBVIE INC.
$42,986
AbbVie, Inc.
$40,472
Novartis Pharmaceuticals Corporation
$35,698
West-Ward Pharmaceuticals
$28,322
AbbVie Inc.
$27,867
Ipsen Biopharmaceuticals, Inc
$25,489
Taiho Oncology, Inc.
$15,000
Sumitomo Pharma America, Inc.
$11,192
AstraZeneca Pharmaceuticals LP
$9,285
Janssen Global Services, LLC
$7,849
Takeda Pharmaceuticals U.S.A., Inc.
$7,181
Rigel Pharmaceuticals, Inc.
$6,500
Daiichi Sankyo Inc.
$5,887
Astellas Pharma US Inc
$4,562
Genentech USA, Inc.
$3,409
Gilead Sciences, Inc.
$3,020
Janssen Research & Development, LLC
$2,860
Adaptive Biotechnologies Corporation
$2,500
NOVARTIS PHARMACEUTICALS CORPORATION
$2,200
Servier Pharmaceuticals LLC
$1,650
E.R. Squibb & Sons, L.L.C.
$170
Jazz Pharmaceuticals Inc.
$158
JAZZ PHARMACEUTICALS INC.
$149
Genentech, Inc.
$84
WHITEHALL INTERNATIONAL INC
$62
Top 3 companies account for 40.3% of all-time payments
Associated products mentioned in payments ›
ABL002 · BESPONSA · BOSULIF · Blincyto · Dasatinib · ELZONRIS · ICLUSIG · INQOVI · KYMRIAH · Kyprolis · Nplate · Oncology TA · RYLAZE · Rezlidhia · TASIGNA · TIBSOVO · VENCLEXTA · VYXEOS · Venclexta · XOSPATA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Houston?
Compare medical oncologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
185
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kantarjian is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kantarjian experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Kantarjian performed 405 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kantarjian receive payments from pharmaceutical companies?
Yes. Dr. Kantarjian received a total of $564,542 from 29 companies across 249 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kantarjian's costs compare to other medical oncologists in Houston?
Dr. Kantarjian's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kantarjian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →